{
    "xml": "<topic id=\"PHP7985\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/silver-sulfadiazine\" basename=\"silver-sulfadiazine\" title=\"SILVER SULFADIAZINE\">\n<title>SILVER SULFADIAZINE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_206\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/sulfonamides/sulfadiazine\">Sulfadiazine</xref>\n</p>\n<data name=\"vtmid\">19630009</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_821628472\" title=\"Sulfonamides\">Sulfonamides</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP41188\" outputclass=\"indicationsAndDose\" rev=\"1.34\" parent=\"/drugs/silver-sulfadiazine\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prophylaxis and treatment of infection in burn wounds</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">To the skin</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child</p>\n<p>Apply daily, may be applied more frequently if very exudative.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Apply daily, may be applied more frequently if very exudative.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">For conservative management of finger-tip injuries</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">To the skin</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child</p>\n<p>Apply every 2&#8211;3&#8239;days, consult product literature for details.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Apply every 2&#8211;3&#8239;days, consult product literature for details.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Adjunct to prophylaxis of infection in skin graft donor sites and extensive abrasions</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">To the skin</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>(consult product literature).</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Adjunct to short-term treatment of infection in pressure sores</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">To the skin</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Apply once daily or on alternate days.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">As an adjunct to short-term treatment of infection in leg ulcers</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">To the skin</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Apply once daily or on alternate days, not recommended if ulcer is very exudative.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP41136\" outputclass=\"unlicensedUse\" rev=\"1.11\" parent=\"/drugs/silver-sulfadiazine\">\n<title>Unlicensed use</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">topical</ph> use in children</p>\n<p>No age range specified by manufacturer.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP41212\" outputclass=\"contraindications\" rev=\"1.11\" parent=\"/drugs/silver-sulfadiazine\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<p>\n<ph outputclass=\"contraindication\">Not recommended for neonates</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP41221\" outputclass=\"cautions\" rev=\"1.15\" parent=\"/drugs/silver-sulfadiazine\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">G6PD deficiency</ph>\n</p>\n</section>\n<section outputclass=\"importantAdvice\">\n<title>Cautions, further information</title>\n<sectiondiv>\n<p outputclass=\"title\">Large areas</p>\n<p>Plasma-sulfadiazine concentrations may approach therapeutic levels with <i>side-effects</i> and <i>interactions</i> as for sulfonamides if large areas of skin are treated.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP41182\" outputclass=\"interactions\" rev=\"1.10\" parent=\"/drugs/silver-sulfadiazine\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (sulfonamides)&#8212;if large amounts given.</p>\n<p>May inactivate enzymatic debriding agents&#8212;concomitant use may be inappropriate.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP41148\" outputclass=\"sideEffects\" rev=\"1.29\" parent=\"/drugs/silver-sulfadiazine\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Allergic reactions</ph>; <ph outputclass=\"sideEffect\">argyria (following treatment of large areas of skin or prolonged use)</ph>; <ph outputclass=\"sideEffect\">burning</ph>; <ph outputclass=\"sideEffect\">itching</ph>; <ph outputclass=\"sideEffect\">leucopenia</ph>; <ph outputclass=\"sideEffect\">rashes</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsAdvice\">\n<title>Side-effects, further information</title>\n<sectiondiv>\n<p outputclass=\"title\">Severe blood and skin disorders</p>\n<p>Owing to the association of sulfonamides with severe blood and skin disorders, treatment should be stopped immediately if blood disorders or rashes develop.</p>\n<p>Leucopenia developing 2&#8211;3 days after starting treatment of burns patients is reported usually to be self-limiting and silver sulfadiazine need not usually be discontinued provided blood counts are monitored carefully to ensure return to normality within a few days.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP41238\" outputclass=\"allergyAndCrossSensitivity\" rev=\"1.13\" parent=\"/drugs/silver-sulfadiazine\">\n<title>Allergy and cross-sensitivity</title>\n<body>\n<section outputclass=\"allergyAndCrossSensitivityContraindications\">\n<sectiondiv>\n<p>Contra-indicated in patients with sensitivity to sulfonamides.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP41174\" outputclass=\"pregnancy\" parent=\"/drugs/silver-sulfadiazine\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Risk of neonatal haemolysis and methaemoglobinaemia in third trimester.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP41232\" outputclass=\"breastFeeding\" parent=\"/drugs/silver-sulfadiazine\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Small risk of kernicterus in jaundiced infants and of haemolysis in G6PD-deficient infants.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP41192\" outputclass=\"hepaticImpairment\" parent=\"/drugs/silver-sulfadiazine\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises caution if significant impairment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP41163\" outputclass=\"renalImpairment\" parent=\"/drugs/silver-sulfadiazine\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises caution if significant impairment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP41130\" outputclass=\"monitoringRequirements\" parent=\"/drugs/silver-sulfadiazine\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p>Monitor for leucopenia.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP41242\" outputclass=\"directionsForAdministration\" rev=\"1.7\" parent=\"/drugs/silver-sulfadiazine\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p>Apply with sterile applicator.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP7985-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/silver-sulfadiazine\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75860\" title=\"Cream\" namespace=\"/drugs/silver-sulfadiazine/cream\">Cream</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78284\" namespace=\"/treatment-summaries/skin-infections\" title=\"Skin infections\" count=\"1\" rel=\"backlink\">Skin infections</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_206\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/sulfonamides/sulfadiazine\" title=\"Sulfadiazine\" count=\"1\" rel=\"link\">Sulfadiazine</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75860\" namespace=\"/drugs/silver-sulfadiazine/cream\" title=\"Cream\" count=\"1\" rel=\"link\">Cream</xref>\n</links>\n</topic>",
    "id": "PHP7985",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/silver-sulfadiazine",
    "basename": "silver-sulfadiazine",
    "title": "SILVER SULFADIAZINE",
    "interactants": [
        {
            "id": "bnf_int_206",
            "label": "Sulfadiazine"
        }
    ],
    "vtmid": "19630009",
    "drugClassification": [
        "Sulfonamides"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Prophylaxis and treatment of infection in burn wounds",
                        "html": "Prophylaxis and treatment of infection in burn wounds"
                    }
                ],
                "specificity": {
                    "routes": [
                        "To the skin"
                    ],
                    "textContent": "To the skin",
                    "html": "To the skin"
                },
                "child": [
                    {
                        "textContent": "Apply daily, may be applied more frequently if very exudative.",
                        "html": "<p>Apply daily, may be applied more frequently if very exudative.</p>"
                    }
                ],
                "adult": [
                    {
                        "textContent": "Apply daily, may be applied more frequently if very exudative.",
                        "html": "<p>Apply daily, may be applied more frequently if very exudative.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "For conservative management of finger-tip injuries",
                        "html": "For conservative management of finger-tip injuries"
                    }
                ],
                "specificity": {
                    "routes": [
                        "To the skin"
                    ],
                    "textContent": "To the skin",
                    "html": "To the skin"
                },
                "child": [
                    {
                        "textContent": "Apply every 2&#8211;3 days, consult product literature for details.",
                        "html": "<p>Apply every 2&#8211;3&#8239;days, consult product literature for details.</p>"
                    }
                ],
                "adult": [
                    {
                        "textContent": "Apply every 2&#8211;3 days, consult product literature for details.",
                        "html": "<p>Apply every 2&#8211;3&#8239;days, consult product literature for details.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Adjunct to prophylaxis of infection in skin graft donor sites and extensive abrasions",
                        "html": "Adjunct to prophylaxis of infection in skin graft donor sites and extensive abrasions"
                    }
                ],
                "specificity": {
                    "routes": [
                        "To the skin"
                    ],
                    "textContent": "To the skin",
                    "html": "To the skin"
                },
                "adult": [
                    {
                        "textContent": "(consult product literature).",
                        "html": "<p>(consult product literature).</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Adjunct to short-term treatment of infection in pressure sores",
                        "html": "Adjunct to short-term treatment of infection in pressure sores"
                    }
                ],
                "specificity": {
                    "routes": [
                        "To the skin"
                    ],
                    "textContent": "To the skin",
                    "html": "To the skin"
                },
                "adult": [
                    {
                        "textContent": "Apply once daily or on alternate days.",
                        "html": "<p>Apply once daily or on alternate days.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "As an adjunct to short-term treatment of infection in leg ulcers",
                        "html": "As an adjunct to short-term treatment of infection in leg ulcers"
                    }
                ],
                "specificity": {
                    "routes": [
                        "To the skin"
                    ],
                    "textContent": "To the skin",
                    "html": "To the skin"
                },
                "adult": [
                    {
                        "textContent": "Apply once daily or on alternate days, not recommended if ulcer is very exudative.",
                        "html": "<p>Apply once daily or on alternate days, not recommended if ulcer is very exudative.</p>"
                    }
                ]
            }
        ]
    },
    "unlicensedUse": {
        "unlicensedUse": [
            {
                "type": "unlicensedUse",
                "specificity": {
                    "textContent": "With topical use in children",
                    "html": "With <ph outputclass=\"route\">topical</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "topical"
                    ]
                },
                "textContent": "No age range specified by manufacturer.",
                "html": "<p>No age range specified by manufacturer.</p>"
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Not recommended for neonates",
                "html": "Not recommended for neonates"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "G6PD deficiency",
                "html": "G6PD deficiency"
            }
        ],
        "importantAdvice": [
            {
                "type": "importantAdvice",
                "title": "Large areas",
                "textContent": "Plasma-sulfadiazine concentrations may approach therapeutic levels with side-effects and interactions as for sulfonamides if large areas of skin are treated.",
                "html": "<p>Plasma-sulfadiazine concentrations may approach therapeutic levels with <i>side-effects</i> and <i>interactions</i> as for sulfonamides if large areas of skin are treated.</p>"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (sulfonamides)&#8212;if large amounts given.\n\nMay inactivate enzymatic debriding agents&#8212;concomitant use may be inappropriate.",
                "html": "<p>Appendix 1 (sulfonamides)&#8212;if large amounts given.</p><p>May inactivate enzymatic debriding agents&#8212;concomitant use may be inappropriate.</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Allergic reactions",
                        "html": "Allergic reactions",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "argyria (following treatment of large areas of skin or prolonged use)",
                        "html": "argyria (following treatment of large areas of skin or prolonged use)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "burning",
                        "html": "burning",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "itching",
                        "html": "itching",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "leucopenia",
                        "html": "leucopenia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "rashes",
                        "html": "rashes",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        },
        "advice": [
            {
                "type": "advice",
                "title": "Severe blood and skin disorders",
                "textContent": "Owing to the association of sulfonamides with severe blood and skin disorders, treatment should be stopped immediately if blood disorders or rashes develop.\n\nLeucopenia developing 2&#8211;3 days after starting treatment of burns patients is reported usually to be self-limiting and silver sulfadiazine need not usually be discontinued provided blood counts are monitored carefully to ensure return to normality within a few days.",
                "html": "<p>Owing to the association of sulfonamides with severe blood and skin disorders, treatment should be stopped immediately if blood disorders or rashes develop.</p><p>Leucopenia developing 2&#8211;3 days after starting treatment of burns patients is reported usually to be self-limiting and silver sulfadiazine need not usually be discontinued provided blood counts are monitored carefully to ensure return to normality within a few days.</p>"
            }
        ]
    },
    "allergyAndCrossSensitivity": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Contra-indicated in patients with sensitivity to sulfonamides.",
                "html": "<p>Contra-indicated in patients with sensitivity to sulfonamides.</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Risk of neonatal haemolysis and methaemoglobinaemia in third trimester.",
                "html": "<p>Risk of neonatal haemolysis and methaemoglobinaemia in third trimester.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Small risk of kernicterus in jaundiced infants and of haemolysis in G6PD-deficient infants.",
                "html": "<p>Small risk of kernicterus in jaundiced infants and of haemolysis in G6PD-deficient infants.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises caution if significant impairment.",
                "html": "<p>Manufacturer advises caution if significant impairment.</p>"
            }
        ]
    },
    "renalImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises caution if significant impairment.",
                "html": "<p>Manufacturer advises caution if significant impairment.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "patientParameters": [
            {
                "type": "patientParameters",
                "textContent": "Monitor for leucopenia.",
                "html": "<p>Monitor for leucopenia.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "textContent": "Apply with sterile applicator.",
                "html": "<p>Apply with sterile applicator.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP75860",
                "label": "Cream",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78284",
                "label": "Skin infections",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_206",
                "label": "Sulfadiazine",
                "type": "interaction"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP75860",
                "label": "Cream",
                "type": "medicinalForm"
            }
        ]
    }
}